NasdaqGS - Nasdaq Real Time Price USD
Editas Medicine, Inc. (EDIT)
1.5347
-0.0253
(-1.63%)
As of 9:40:00 AM EDT. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| BURKLY LINDA Officer | Sale | Mar 4, 2025 | 70,245 |
| EATON BRUCE E Chairman of the Board | Sale | Dec 5, 2023 | 74,791 |
| HOPFIELD JESSICA Director | Purchase | May 13, 2024 | 67,700 |
| LUCERA ERICK J. Chief Financial Officer | Sale | Mar 4, 2025 | 112,720 |
| MEI BAISONG Officer | Sale | Dec 3, 2024 | 133,354 |
| O NEILL GILMORE NEIL Chief Executive Officer | Sale | Mar 4, 2025 | 295,474 |
| ROBERTSON MICHELLE Chief Financial Officer | Sale | May 11, 2023 | 106,610 |
Related Tickers
NTLA Intellia Therapeutics, Inc.
8.07
-0.25%
BEAM Beam Therapeutics Inc.
19.77
-0.53%
CRSP CRISPR Therapeutics AG
38.56
+0.06%
CRBU Caribou Biosciences, Inc.
0.8401
-0.26%
PRME Prime Medicine, Inc.
1.7444
-2.00%
VERV Verve Therapeutics, Inc.
5.49
+0.36%
FATE Fate Therapeutics, Inc.
1.3253
-0.35%
BLUE bluebird bio, Inc.
4.0628
-0.66%
DNA Ginkgo Bioworks Holdings, Inc.
7.81
+2.76%
SGMO Sangamo Therapeutics, Inc.
0.7789
+3.29%